Enteritis

Acetyl-L-carnitine (ALCAR) has been investigated for nerve regeneration in CTS across multiple studies. A large uncontrolled study reported symptom improvement in ~83% of subjects with peripheral nerve dysfunction including CTS patients. However, a subsequent double-blind RCT found no significant benefit of ALCAR alone for severe CTS post-surgery at 3,000 mg/day.

Alpha-lipoic acid (ALA) has been tested in multiple RCTs for carpal tunnel syndrome, primarily as a perioperative neuroprotectant. A 2024 systematic review and meta-analysis of six RCTs found significant improvements in Boston Carpal Tunnel Questionnaire scores, motor nerve distal latency, and VAS pain scores in ALA-treated groups versus placebo.

Bromelain, the proteolytic enzyme complex from pineapple stem, has anti-inflammatory and fibrinolytic effects relevant to nerve compression syndromes. It has been studied as part of a multi-ingredient supplement for early CTS, with statistically significant improvement in nerve function and sleep quality reported. WebMD notes clinical trial evidence in CTS for bromelain-containing combinations.

Curcumin has antioxidant, anti-inflammatory, analgesic, and neuroprotective properties investigated in CTS. A 2024 double-blind, placebo-controlled RCT of topical curcumin gel in 70 CTS patients showed significant improvements in symptom severity and functional status scores. Oral curcumin in combination formulas also significantly reduced CTS-related neuropathic pain in additional clinical trials.

Methylcobalamin is the neurologically active form of vitamin B12 and has been specifically used in CTS multi-ingredient supplement formulas demonstrating improved nerve function and recovery. It promotes peripheral nerve regeneration, reduces neuropathic pain, and is included in validated clinical formulas for CTS perioperative support and conservative management.

N-acetyl cysteine (NAC) is a glutathione precursor with antioxidant properties and has been included in validated clinical supplement formulas for CTS perioperative support alongside ALA, ALCAR, methylcobalamin, curcumin, and serrapeptidase. It reduces oxidative stress implicated in nerve ischemia and compression.

Omega-3 fatty acids (EPA and DHA) reduce inflammatory prostaglandins involved in tenosynovial swelling in the carpal tunnel. Fish oil at 2–3 g/day has been cited in CTS clinical literature as potentially reducing nerve compression by decreasing synovial sheath inflammation, particularly in CTS associated with rheumatoid arthritis or repetitive strain.

Phosphatidylserine is a membrane phospholipid investigated as part of multi-ingredient nutraceutical blends for CTS. A 2021 open-label RCT of a blend containing phosphatidylserine, ALCAR, ALA, curcumin, and vitamins showed significant functional and clinical improvement in mild-to-moderate CTS patients vs. no supplementation.

Quercetin has anti-inflammatory properties and has been studied as part of a multi-ingredient supplement for early CTS alongside bromelain, ALCAR, ALA, and B vitamins. The combination produced statistically significant improvement in nerve function and sleep quality vs. physical therapy alone. Bromelain enhances quercetin's bioavailability and they are often studied together.

Serratiopeptidase (serrapeptase), a proteolytic enzyme derived from Serratia marcescens, was tested in a preliminary clinical trial of 20 CTS patients given 10 mg twice daily for 6 weeks; 65% showed significant clinical and electrophysiological improvement. It is recognized in clinical literature as a potential conservative treatment for CTS.

Vitamin B12 (particularly methylcobalamin) supports peripheral nerve regeneration and myelin integrity. B12 deficiency can produce median nerve dysfunction indistinguishable from mechanical CTS, and B-group vitamins including B12 have shown benefit in CTS combination supplement trials. Life Extension's CTS protocol and clinical reviews support B12 as a reasonable CTS adjunct.

Vitamin B6 (pyridoxine) is the most extensively studied supplement for carpal tunnel syndrome. Multiple clinical trials at 100–150 mg/day for 10–12 weeks have shown improvement in sensory nerve conduction velocity and symptom scores. Evidence is mixed, but a Nutrition Reviews (2004) systematic review concluded supplementation is reasonable for CTS patients.

Vitamin D deficiency has been identified as an independent risk factor for CTS severity and pain. A 2021 systematic review of four studies found that vitamin D supplementation improved pain scores, nerve conduction velocity, and functional status in CTS patients. A 2024 RCT further confirmed clinical and electroneuromyographic improvements with adjuvant vitamin D.

Vitamin D3 is the cholecalciferol form of vitamin D used in supplementation trials for CTS. Vitamin D deficiency is an independent risk factor for CTS, and several studies specifically using vitamin D3 supplementation have demonstrated improved pain, functional status, and nerve conduction in CTS patients. A 2024 RCT confirmed electroneuromyographic and clinical benefits.

Carpal tunnel syndrome is listed as a traditional herbalist indication for prickly ash, specifically noted for paresthesia (pins-and-needles sensations) arising from reduced peripheral circulation and nerve compression. The Learning Herbs monograph identifies this as a use in contemporary herbal practice. No clinical trial evidence supports this use.

Carpal tunnel syndrome involves inflammation and compression of the median nerve within the wrist's connective-tissue tunnel. Western herbalists apply Solomon's seal to repetitive stress injuries including carpal tunnel, citing its anti-inflammatory and connective-tissue normalizing actions.